20
Unimark Remedies Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Albendazole, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2001-448 - Rev 04
This Chemical Type CEP, issued on April 28, 2014, remains in force until April 12, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1386 associated with this CEP further emphasizes